Date |
Acquired company |
Acquiring company |
Amount |
Related |
2017-08-29 |
Patheon (USA - NC) |
Thermo Fisher Scientific (USA - MA) |
$7.2 billion |
Technology - Services |
2017-08-28 |
Protein Sciences (USA - CT) |
Sanofi (France) |
up to $750 million |
Vaccines - Infectious diseases |
2017-08-28 |
Syncom (The Netherlands) |
Mercachem (The Netherlands) |
|
CRO - Technology - Services |
2017-08-28 |
Natrix Separations (Canada) |
Merck KGaA (Germany) |
undisclosed |
Technology - Services |
2017-08-09 |
Cempra (USA - NC) |
Melinta Therapeutics (USA - CT) |
|
Infectious diseases |
2017-08-04 |
Micro-Macinazione (Italy) |
Lonza (Switzerland) |
undisclosed |
Technology - Services |
2017-08-03 |
IFM Therapeutics (USA - MA) |
BMS (USA - NY) |
$300 million upfront with potential of up to $1.01 billion in milestones for each of the first products from the two programs |
Cancer - Oncology - Autoimmune diseases - Inflammatory diseases |
2017-08-01 |
BMS’s pharmaceutical manufacturing facility in Bothell (USA -WA ) |
Seattle Genetics (USA -WA ) |
undisclosed |
|
2017-07-31 |
DiscoverX (USA - CA) |
Eurofins Scientific (Luxembourg) |
undisclosed |
Technology - Services |
2017-07-27 |
GATC Biotech (Germany) |
Eurofins Scientific (Luxembourg) |
undisclosed |
Technology - Services |
2017-07-27 |
Mapi Group (France) |
Icon (Ireland) |
undisclosed |
CRO |
2017-07-26 |
Advinus Therapeutics (India) |
Eurofins Scientific (Luxembourg) |
undisclosed |
Technology - Services |
2017-07-20 |
Akorn (USA - IL) |
Fresenius Kabi (Germany) |
$4.75 billion |
generics |
2017-07-18 |
TomTec Imaging Systems (Germany) |
Philips (The Netherlands) |
undisclosed |
Technology - Services |
2017-07-17 |
Merus Labs International (Canada) |
Norgine (The Netherlands) |
C$342 million |
|
2017-07-10 |
Amatsigroup (France) |
Eurofins Scientific (Luxembourg) |
€ 130 million |
Technology - Services |
2017-07-06 |
Capsugel (USA - NJ) |
Lonza (Switzerland) |
$ 5.5 billion |
Technology - Services - Bioproduction - Manufacturing |
2017-06-30 |
mySugr (Austria) |
Roche (Switzerland) |
undisclosed |
diabetes |
2017-06-28 |
True North Therapeutics (USA - CA) |
Bioverativ (USA - MA) |
up to $825 million |
Genetic diseases - Rare diseases - Hematological disease |
2017-06-26 |
Innova Biosciences (UK) |
Sygnis (Germany) |
|
|